Determinants of Survival Without Antiretroviral Therapy After Infancy in HIV-1-Infected Zambian Children in the CHAP Trial

Background: There are few data on predictors of HIV progression in untreated children in resource-limited settings. Methods: Children with HIV Antibiotic Prophylaxis (CHAP) was a randomized trial comparing cotrimoxazole prophylaxis with placebo in HIV-infected Zambian children. The prognostic value of baseline characteristics was investigated using Cox models. Results: Five hundred fourteen children aged 1 to 14 (median 5.5) years contributed 607 years follow-up (maximum 2.6 years). Half were boys, and in 67%, the mother was the primary carer; at baseline, median CD4 percentage was 11% and weight was less than third percentile in 67%. One hundred sixty-five children died (27.2 per 100 years at risk; 95% confidence interval 23.3-31.6). Low weight-for-age, CD4 percentage, hemoglobin, mother as primary carer, current malnutrition, and previous hospital admissions for respiratory tract infections or recurrent severe bacterial infections were independent predictors of poorer survival, whereas oral candidiasis predicted poorer survival only when baseline CD4 percentage was not considered. Mortality rates per 100 child years of 44.5 (37.2-53.2), 14.7 (10.9-19.8), and 2.3 (0.3-16.7) were associated with new World Health Organization stages 4, 3, and 1/2, respectively, applied retrospectively; very low weight-for-age was the only staging feature for 42% of stage 4 children. Conclusions: Malnutrition and hospitalizations for respiratory/bacterial infections predict mortality independent of immunosuppression, suggesting that they capture HIV- and non-HIV-related mortality, whereas oral candidiasis is a proxy for immunosuppression.

[1]  J. Salomon,et al.  Estimating the Net Effect of HIV on Child Mortality in African Populations Affected by Generalized HIV Epidemics , 2005, Journal of acquired immune deficiency syndromes.

[2]  Alimuddin Zumla,et al.  Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study , 2002, The Lancet.

[3]  Alimuddin Zumla,et al.  Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial , 2004, The Lancet.

[4]  M. Zeier,et al.  The first 5 years of the family clinic for HIV at Tygerberg Hospital: family demographics, survival of children and early impact of antiretroviral therapy. , 2006, Journal of tropical pediatrics.

[5]  Douglas G Altman,et al.  Dichotomizing continuous predictors in multiple regression: a bad idea , 2006, Statistics in medicine.

[6]  C. Giaquinto,et al.  Use of total lymphocyte count for informing when to start antiretroviral therapy in HIV-infected children: a meta-analysis of longitudinal data , 2005, The Lancet.

[7]  M. de Martino,et al.  Prognostic factors and survival in children with perinatal HIV-1 infection. The Italian Register for HIV Infections in Children. , 1992, Lancet.

[8]  Alimuddin Zumla,et al.  Impact of the human immunodeficiency virus type-1 on common pediatric illnesses in Zambia. , 1995, Journal of tropical pediatrics.

[9]  P. Royston,et al.  Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling. , 1994 .

[10]  P. Royston,et al.  Building multivariable prognostic and diagnostic models: transformation of the predictors by using fractional polynomials , 1999 .

[11]  D. Dunn.  Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis , 2003, The Lancet.

[12]  M. Zappa,et al.  Predictive value of the HIV paediatric classification system for the long-term course of perinatally infected children. , 2000, International journal of epidemiology.

[13]  L. Marum,et al.  Care of children with HIV infection and AIDS in Africa. , 1997, AIDS.

[14]  A. Plebani,et al.  Prognostic factors and survival in children with perinatal HIV-1 infection , 1992, The Lancet.

[15]  H. Barnhart,et al.  Natural history of human immunodeficiency virus disease in perinatally infected children: an analysis from the Pediatric Spectrum of Disease Project. , 1996, Pediatrics.

[16]  Nigel Rollins,et al.  Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis , 2004, The Lancet.

[17]  C.G.A. Mcgregor.  Progress on Global Access to HIV Antiretroviral Therapy , 2006 .

[18]  C. Gilks,et al.  Paediatric HIV infection in a rural South African district hospital. , 2000, Journal of tropical pediatrics.

[19]  P. Royston,et al.  Stability of multivariable fractional polynomial models with selection of variables and transformations: a bootstrap investigation , 2003, Statistics in medicine.

[20]  D. Hoover,et al.  Morbidity among human immunodeficiency virus-1-infected and -uninfected African children. , 2000, Pediatrics.

[21]  C. Rouzioux,et al.  Morbidity and mortality in European children vertically infected by HIV-1. The French Pediatric HIV Infection Study Group and European Collaborative Study. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[22]  James Curran,et al.  Scaling Up Antiretroviral Therapy in Resource-Limited Settings: Treatment Guidelines for a Public Health Approach , 2005 .

[23]  T. O'connor,et al.  Survival in children with perinatally acquired human immunodeficiency virus type 1 infection , 1990, The New England journal of medicine.

[24]  D. Blaauw,et al.  Diagnosis of paediatric HIV infection in a primary health care setting with a clinical algorithm. , 2003, Bulletin of the World Health Organization.

[25]  M. Cowles,et al.  Treatment-mediated changes in human immunodeficiency virus (HIV) type 1 RNA and CD4 cell counts as predictors of weight growth failure, cognitive decline, and survival in HIV-infected children. , 2000, The Journal of infectious diseases.

[26]  G. Hussey,et al.  Survival of children in Cape Town known to be vertically infected with HIV-1. , 1998, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[27]  T J Cole,et al.  British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood. , 1998, Statistics in medicine.

[28]  A. Crampin,et al.  HIV and Mortality of Mothers and Children: Evidence From Cohort Studies in Uganda, Tanzania, and Malawi , 2005, Epidemiology.

[29]  C. Giaquinto,et al.  Comparison of dual nucleoside-analogue reverse-transcriptase inhibitor regimens with and without nelfinavir in children with HIV-1 who have not previously been treated: the PENTA 5 randomised trial , 2002, The Lancet.

[30]  H. Boshuizen,et al.  Multiple imputation of missing blood pressure covariates in survival analysis. , 1999, Statistics in medicine.

[31]  Tim Evans,et al.  Health information in the new millennium: a gathering storm? , 2003, Bulletin of the World Health Organization.

[32]  N. McIntosh,et al.  Forfar and Arneil's Textbook of Pediatrics , 1992 .

[33]  A E Ades,et al.  Age-related reference ranges: significance tests for models and confidence intervals for centiles. , 1994, Statistics in medicine.

[34]  M. Molyneux,et al.  Clinical presentation and outcome of Pneumocystis carinii pneumonia in Malawian children , 2000, The Lancet.

[35]  R. Biggar,et al.  Association of HIV-1 load and CD4 lymphocyte count with mortality among untreated African children over one year of age , 2000, AIDS.

[36]  E. Karita,et al.  Natural History of Human Immunodefiency Virus Type 1 Infection in Children: A Five-Year Prospective Study in Rwanda , 1999, Pediatrics.

[37]  H. Zar,et al.  Pneumocystis carinii pneumonia in South African children infected with human immunodeficiency virus , 2000, The Pediatric infectious disease journal.